Long-term outcomes in Waldenström macroglobulinemia (WM) patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
A new study published in ‘Frontiers in Immunology' has found that both insomnia and anxiety are linked to a weaker immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback